Democrats target drug pricing—again—with new economic plan. Will it work this time?

Fierce Pharma ------- Democrats rolled out their new economic agenda Monday, calling it a “Better Deal.” For consumers, that might be true. For the pharma industry, not so much. Among proposals Sen. Chuck Schumer and Rep. Nancy Pelosi say will foster wage growth and cut everyday expenses for average Americans are a couple of direct stabs at drug prices. Neither of them is entirely new: Congressional Democrats would push for stepped-up negotiating powers for Medicare and legal measures to fight big price hikes on older drugs. But with pricing heat that intensifies with every new scandal, public sentiment is behind government action to bring down drug prices. In fact, 92% of Americans back Medicare price negotiation, according to an April survey by the Kaiser Family Foundation, and 86% support requiring pharma companies to release information on their pricing decisions. To learn more click on the picture below to read the article.